Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

TRT in Canada: The Definitive Guide

Who prescribes, the tests you need, what each drug plan covers, what it costs, and the rules that change on 1 October 2026.

TRT in Canada at a glance.

TRT in Canada at a glance. Testosterone is a Schedule IV controlled substance, prescription only, and banned in sport. A family doctor or nurse practitioner can prescribe it after symptoms and a low morning blood test; the Canadian Urological Association uses total testosterone below 10 nmol/L, drawn between 7 and 11 am. Doctor visits and most tests are publicly insured, and provincial drug plans cover testosterone with conditions: every provincial plan lists injections, while gels are listed with conditions in Ontario and three Atlantic provinces, without conditions in Quebec, and not at all in the four western provinces. Virtual-care prescribers must usually be licensed in your province; British Columbia is the exception. New Controlled Substances Regulations take effect on 1 October 2026. The map is schematic, and the route shows the usual steps anywhere in Canada: a prescriber, a morning blood test, a pharmacy and follow-up.

TRT in Canada

Getting prescribed testosterone in Canada: who prescribes, the tests, who pays and the rules

Schedule IV controlled substance Prescription only Health Canada approves products (DIN) Provinces run insurance, drug plans and licensing WADA prohibited

  • 13 provinces and territorieseach runs its own insurance, drug plan and licensing
  • Routethe usual steps, anywhere in Canada

Schematic: the map shape is simplified and the route does not represent any one province.

How it works

From federal law, provincial drug plans and the CUA guideline, checked September 2026

  1. Diagnosis first

    Symptoms plus a low morning test; CUA uses below 10 nmol/L.

    Canadian Urological Association guideline, 2021

  2. Provincial coverage

    Every provincial plan lists injections; gel coverage varies by province.

    Provincial and federal drug-plan lists

  3. Licensing by province

    Virtual prescribers follow the rules where you live; BC differs.

    Medical colleges of Ontario, Alberta, Quebec and BC

  4. 1 October 2026

    New regulations: 90-day travel supply, pharmacist extensions and transfers.

    Controlled Substances Regulations

Who prescribes

Family doctor or nurse practitioner

No specialist required; referral for pituitary or genetic causes

Tests needed

Morning total testosterone

CUA: below 10 nmol/L (288 ng/dL), 7–11 am; confirm on another day (Choosing Wisely Canada)

Coverage

Provincial drug plans, with conditions

Visits and most tests insured; not national pharmacare

Telehealth rule

Licensed where you live

Ontario, Alberta and Quebec require it; BC does not

Conceptual summary of the Canadian pathway. Who prescribes, the tests, the coverage rules and the virtual-care rules come from federal law, provincial drug plans, medical colleges and the Canadian Urological Association guideline cited in this guide (checked September 2026). The map shape is schematic.
Published by DoserlyUpdated Next scheduled review: November 202632 min readHow this guide was made
In this guide

What is TRT, and how does it work in Canada?

In Canada, TRT is testosterone prescribed by a doctor or nurse practitioner after symptoms and a low morning blood test. Provincial health insurance pays for the visits and most of the tests. The medicine itself is paid by a provincial or federal drug plan (usually with conditions), a private plan, or you. [3], [28], [6]

Testosterone replacement therapy is prescribed testosterone for men whose bodies do not make enough of it, a condition called hypogonadism or testosterone deficiency. In Canada it comes as injections, skin gels, a nasal gel and capsules. [3], [15]

Responsibility is split between governments. Health Canada approves each product and gives it a Drug Identification Number (DIN). Federal law controls testosterone as a Schedule IV drug. Each province runs its own health insurance, its own drug plan and the college that licenses its doctors, which is why the path and the price depend on where you live. [15], [1], [29]

Experiences vary a lot. In a 2013 Canada-wide needs assessment cited by the CUA, over 25% of Canadian physicians said they were uncomfortable diagnosing and treating testosterone deficiency. The CUA guideline was written partly to close that gap. [3]

QuestionCanada, checked September 2026
Who approves productsHealth Canada (each product has a DIN)
Legal statusSchedule IV controlled substance, prescription only; possessing your own supply is not an offence
Who can prescribePhysicians and nurse practitioners, within provincial rules
Main clinical guidelineCanadian Urological Association, 2021
Who pays for the medicineProvincial and federal drug plans (with conditions), private plans or the patient; not national pharmacare
SportProhibited at all times by the World Anti-Doping Agency

[15], [1], [2], [3], [6], [27]

How do you get TRT in Canada?

Most men start with a family doctor or nurse practitioner, have a morning blood test that is usually repeated, get a few baseline safety checks, and fill the prescription at any pharmacy. A specialist, or a virtual clinic whose prescriber meets your province's licensing rules, are the other routes. The figure shows the six core steps; the list below adds two that not everyone needs (referral, and checking which form your plan covers). Checked September 2026.

Flow chart of the usual Canadian route to a testosterone prescription in six core steps: see a family doctor or nurse practitioner, symptoms and a morning blood test, find the cause, baseline safety checks, fill at a pharmacy, follow-up. Side branches show referral and virtual care.

How to get a testosterone prescription in Canada

The six core steps, with who does each step and who usually pays. Checked September 2026.

  1. 1.See a family doctor, nurse practitioner or walk-in clinic
    No specialist requiredWho: Physician or nurse practitioner
    Usually paid by: Provincial health insurance
  2. Side route after step 1: Or a virtual clinicPrescriber must meet your province's licensing rules (Ontario, Alberta, Quebec require local registration; BC does not)
  3. 2.Symptoms, then a morning blood test
    CUA: total testosterone 7–11 am; below 10 nmol/L (288 ng/dL) is a reasonable threshold; confirm on another day (Choosing Wisely Canada)Who: Lab, with a requisition
    Usually paid by: Provincial health insurance
  4. 3.Find the cause
    LH for all; prolactin if secondary; reversible causes firstWho: Prescriber
    Usually paid by: Provincial health insurance
  5. Side route after step 3: Referral if neededSuspected pituitary or genetic cause (BC protocol). Nova Scotia endocrinology: median 70 days, 90th percentile 318 days (Jan–Mar 2026)
  6. 4.Baseline safety checks
    Hematocrit, PSA, rectal exam; discuss fertilityWho: Prescriber and lab
    Usually paid by: Mostly insured; routine PSA may not be (Ontario, BC)
  7. 5.Prescription filled at a pharmacy
    Drug plan rules decide which form is coveredWho: Any community pharmacy
    Usually paid by: Drug plan, private insurance or you
  8. 6.Follow-up
    CUA: testosterone and PSA at 3 and 6 months, then yearly; hematocrit at 3 months, then yearlyWho: Prescriber
    Usually paid by: Provincial health insurance

Checked September 2026. Provincial rules differ; this is the common route, not a legal requirement.

The usual Canadian route to a testosterone prescription, step by step, with who does each step and where public insurance usually pays. Referral and virtual care are side routes. Based on the CUA guideline, British Columbia's testing protocol, Choosing Wisely Canada and provincial rules, checked September 2026. Sources: CUA guideline 2021 · BC testosterone testing protocol · Choosing Wisely Canada (CSEM) · FMRAC telemedicine framework.
  1. Book a family doctor, nurse practitioner or walk-in clinic. Physicians can prescribe testosterone, and federal rules expressly let nurse practitioners prescribe it within their province's scope of practice. No federal rule or Canadian guideline requires a specialist to start treatment. [2], [25], [3]
  2. Describe your symptoms, then have a morning blood test. The CUA recommends a total testosterone drawn between 7 and 11 am, and Choosing Wisely Canada advises against testing men who have no symptoms. British Columbia's protocol asks for the draw before 10 am or within 3 hours of waking, preferably fasting. Choosing Wisely Canada also says a low result should be confirmed on a different day. [3], [30], [31], [4]
  3. Look for the cause. If testosterone is low, the CUA advises measuring luteinizing hormone (LH) to tell primary from secondary hypogonadism, and prolactin when it is secondary. It also advises checking for reversible causes before starting, such as obesity, opioid or glucocorticoid (steroid) medicines, sleep apnea or a pituitary problem. [3]
  4. Baseline safety checks. Before treatment, the CUA and British Columbia's protocol check hematocrit and prostate-specific antigen (PSA), along with a digital rectal exam. Men who want children should raise it now, because testosterone lowers sperm production. [3], [31] See TRT and fertility.
  5. Referral, if needed. No referral is required, but British Columbia's protocol suggests one for a suspected pituitary or hypothalamic tumour, high prolactin, hemochromatosis, genetic conditions or undescended testes. Specialist waits vary. The only official figure we found is from Nova Scotia's Halifax endocrinology clinic: half of new referrals were seen within 70 days and 90% within 318 days (January to March 2026). [31], [32]
  6. Choose a form and check your drug plan. Your prescriber chooses from the products marketed in Canada; your drug plan may cover some forms and not others (see coverage by province).
  7. Fill the prescription. Any community pharmacy can fill it. The prescriber decides how many refills to allow, and the prescription can be written or given to the pharmacist by phone. [33], [25]
  8. Follow-up. Expect blood tests at about 3 and 6 months and then yearly (see follow-up). [3]

Can a family doctor or nurse practitioner prescribe testosterone?

Yes. Federal rules name testosterone as a controlled drug nurse practitioners may prescribe, and that continues under the new regulations from 1 October 2026, within what each province authorizes. None of the drug-plan criteria we read requires a specialist prescriber. In practice, many readers describe family doctors who decline to test or treat; see what people report. [2], [25], [5], [34]

Can you get TRT through a virtual (online) clinic?

Yes. Virtual care is allowed as long as the prescriber meets the licensing rules of the province you are in, and those rules differ. The national framework for medical regulators says physicians must follow the licensing requirements where the patient is located and assess a patient before prescribing. Federal law sets no separate registration for prescribing controlled drugs by telehealth; the rules come from each province's medical college. [35], [1]

Province (college)Does the doctor need a licence in your province?Extra prescribing rules
Ontario (CPSO)Yes, with exceptions: care not readily available in Ontario (such as specialty care), bridging a gap in an existing relationship, or urgent careVirtual care must meet the same standard as in-person care, including for prescribing
Alberta (CPSA)Yes, with similar exceptions"Controlled medications" only after an in-person exam, within an ongoing treating relationship, or in contact with a professional who examined you. The college has not said how this applies to testosterone
Quebec (CMQ)Yes, a Quebec permit for regular care of Quebec patientsTeleconsultation rules single out narcotics, benzodiazepines and psychostimulants, not testosterone
British Columbia (CPSBC)No: a doctor licensed by another regulator does not need a BC licence, but cannot see PharmaNet, BC's medication recordTake care prescribing for patients not personally examined; episodic virtual care needs links to in-person care where the patient lives

[29], [36], [37], [38], [39]

Other provinces and the territories were not checked for this guide. Checked September 2026.

Two rules matter if you use an online clinic and a family doctor at the same time. Under federal law, you must tell a prescriber about any testosterone prescription you received from another practitioner in the previous 30 days. And pharmacies keep records. Ontario added Taro's testosterone cypionate to its Monitored Drugs List in November 2020, so dispensing it is reported to the province's Narcotics Monitoring System. British Columbia's duplicate-pad Controlled Prescription Program and Alberta's Tracked Prescription Program do not cover testosterone. [1], [40], [41], [42]

How do you get blood tests without a family doctor?

You need a requisition. In Ontario, only authorized practitioners can order publicly insured lab tests, and a requisition is valid for 6 months. Doctors at walk-in and virtual clinics can write them, and some readers pay for private testing instead. Alberta stopped charging patients for bioavailable testosterone tests in April 2024. [28], [43], [44], [45]

What does Canada require to qualify for TRT?

Two separate things: a diagnosis to get a prescription, and your drug plan's criteria to get the medicine paid for. A doctor can prescribe testosterone to a man the plan will not cover.

What testosterone level do Canadian doctors require?

There is no legal cut-off. Canadian guidance asks for symptoms plus a low morning result, and the numbers differ. Checked September 2026.

Guideline (version, year)ThresholdHow measuredAction at this level
CUA, Canadian Urological Association (2021)Total testosterone below 10 nmol/L (288 ng/dL)Morning draw, 7–11 am; free or bioavailable testosterone if borderlineA reasonable threshold, used alongside symptoms; the CUA calls the level a supporting tool, not an absolute test
BC Guidelines testing protocol (revised 2022)Below the lab's lower limit: about 8 nmol/L (231 ng/dL) under age 30 and about 6 nmol/L (173 ng/dL) over 50Before 10 am or within 3 hours of waking, preferably fasting; bioavailable testosterone (cBAT) if borderlineConfirm the deficiency and its cause; test only men with symptoms
Choosing Wisely Canada, Canadian Society of Endocrinology and MetabolismBiochemical evidence of deficiencyMorning total testosterone, with a low result confirmed on a different dayDo not prescribe without it
Choosing Wisely Canada, CUASymptoms firstSerum testosteroneDo not test men without symptoms; no testosterone for erectile dysfunction when levels are normal
For comparison: AUA, American Urological AssociationBelow 300 ng/dL (10.4 nmol/L)Two early-morning testsA reasonable cut-off for diagnosis

[3], [31], [4], [30], [46]

Canadian bodies agree on the basics: symptoms plus a low morning level. They draw the line in different places. The CUA uses 10 nmol/L. British Columbia's protocol uses each lab's own lower limit, about 6 to 8 nmol/L depending on age. The CUA itself notes that some men have symptoms at higher levels. [3], [31]

Canadian labs report testosterone in nmol/L, while most US sources and forums use ng/dL. To convert, multiply nmol/L by 28.84; the testosterone unit converter does it for you. [3]

Scale in nmol/L and ng/dL showing British Columbia's lab-based lower limits at about 6 and 8 nmol/L, the CUA threshold at 10 nmol/L (288 ng/dL) and, for comparison, the AUA's 300 ng/dL (10.4 nmol/L).

Where Canadian guidance draws the line for low testosterone

Morning total testosterone, in nmol/L (Canadian labs) with ng/dL below.

Each line runs from 4 nmol/L (about 115 ng/dL, left) to 12 nmol/L (about 346 ng/dL, right); the thin mark is 10 nmol/L. A shaded bar is a range; a dashed circle is the US comparison.

British Columbia (BC Guidelines testing protocol, 2022)
Below the lab's lower limit: about 6 nmol/L over 50, about 8 under 30
CUA (Canadian Urological Association, 2021)
Below 10 nmol/L (288 ng/dL), morning draw 7–11 am
For comparison: AUA (American Urological Association (US))
Below 300 ng/dL (10.4 nmol/L), two early-morning tests

Every source also requires symptoms; the CUA calls the level a supporting tool, not an absolute test. Checked September 2026. 1 nmol/L = 28.84 ng/dL.

Where Canadian guidance draws the line for low testosterone, on one scale in nmol/L with ng/dL below: British Columbia's lab-based limits for older and younger men, the CUA's 10 nmol/L and, for comparison, the AUA's 300 ng/dL. Every source also requires symptoms. Sources: CUA guideline 2021 · BC testosterone testing protocol · AUA guideline.

Where do Canadian rules disagree?

  • One test or two. The CUA recommends a morning total testosterone and does not require a second draw. Choosing Wisely Canada says to confirm a low result on another day. Several drug plans also ask for two tests before they pay for gels. New Brunswick wants two separate free testosterone measurements, and Nova Scotia and Prince Edward Island two biochemical tests. [3], [4], [13], [12], [14]
  • Older men with vague symptoms. The CUA guideline sets no age limit, and it cites benefits seen in older men with symptoms in the T Trials. A 2025 evidence summary for Canadian family doctors is more cautious. In healthy older men or men with age-related low testosterone, it found about 1.6 kg more lean body mass but "no consistent, meaningful impact on sexual function, strength, fatigue, or cognition". Ontario, New Brunswick and the federal plan for First Nations and Inuit (NIHB, for gels) all exclude older men with nonspecific symptoms. Alberta will not pay for the oral capsule for age-related decline. That gap explains many refusals. [3], [47], [5], [13], [48], [9]
  • Reversible causes first. The CUA advises treating causes such as obesity, sleep apnea, opioid use or high prolactin and then re-checking testosterone before starting treatment. [3]

Which public drug plans cover testosterone?

Every provincial plan we read lists testosterone injections, some with conditions, so injections are the easiest form to get covered. Each plan publishes a formulary, its list of covered drugs, and sets its own rules about who can join. In Ontario, for example, the public plan covers people 65 and over, people 24 and under without private insurance, and people on social assistance. It also covers people in the Trillium Drug Program, which helps households whose drug costs are high compared with their income. Checked September 2026. [49], [50]

PlanInjections (cypionate, enanthate)1% gelsOral undecanoate 40 mgMain conditions
Ontario Drug BenefitLimited UseLimited Use (AndroGel, Taro gel, Testim)Limited UseCode 397: a confirmed low morning level with documented, symptomatic hypothalamic, pituitary or testicular disease, or HIV; 1-year authorization; older men with nonspecific symptoms and a low-normal random level do not qualify
Quebec RAMQListedListedListedRegular list, not "exceptional medications"
British Columbia PharmaCareSpecial AuthorityNot a benefitListed without a price; status unclearListed diagnoses, including hypogonadism, removed or undescended testes, Klinefelter syndrome and pituitary tumour or removal; approval has no end date
Alberta government plansListedNot listedSpecial authorizationOral: primary or secondary hypogonadism, not age-related decline; 6-month approvals
Saskatchewan Drug PlanListedNot listedListedNone stated
Manitoba PharmacareListed (Part 1)Not foundListed (Part 1)None stated
Nova Scotia PharmacareListedException statusListedGels: a named cause, two biochemical tests, up to 5 g a day
New Brunswick Drug PlansListed (open)Special AuthorizationSpecial AuthorizationA named cause and two separate free testosterone measurements; gel up to 5 g a day; oral approved for 1 year
Prince Edward Island PharmacareListed for several programsSpecial AuthorizationSpecial Authorization after injections failA named cause, two biochemical tests; gel up to 5 g a day
Newfoundland and LabradorCypionate listed (open)Not verifiedSpecial AuthorizationFills limited to 30 days
NIHB (First Nations and Inuit, all provinces and territories)Open benefitLimited useOpen benefitGels: removed or undescended testes, Klinefelter syndrome, pituitary tumour or surgery with low testosterone, and other listed uses; older men with nonspecific symptoms do not qualify
Northwest TerritoriesFollows the NIHB listFollows the NIHB listFollows the NIHB listNIHB criteria
Veterans Affairs CanadaSpecial authorizationSpecial authorizationSpecial authorizationNot a standard benefit
Yukon, Nunavut (residents without NIHB)Not verifiedNot verifiedNot verifiedNot verified

[17], [5], [49], [7], [34], [8], [9], [10], [11], [12], [13], [14], [18], [48], [51], [52], [53]

Grid of Canadian public drug plans against three forms of testosterone, showing listed, listed with conditions, not listed or not verified for each. Every provincial plan lists injections, some with conditions; gels are usually conditional or not listed.

Which public drug plans list testosterone, by form

Status on each plan's published list. Checked September 2026.

  • Listed
  • Listed with conditions
  • Not listed
  • Not verified

Ontario Drug Benefit

  • Injections: Listed with conditions (Limited Use 397)
  • 1% gels: Listed with conditions (Limited Use 397)
  • Oral capsules: Listed with conditions (Limited Use 397)

Quebec RAMQ

  • Injections: Listed
  • 1% gels: Listed
  • Oral capsules: Listed

BC PharmaCare

  • Injections: Listed with conditions (Special Authority)
  • 1% gels: Not listed
  • Oral capsules: Not verified (listed without a price)

Alberta

  • Injections: Listed
  • 1% gels: Not listed
  • Oral capsules: Listed with conditions (special authorization)

Saskatchewan

  • Injections: Listed
  • 1% gels: Not listed
  • Oral capsules: Listed

Manitoba

  • Injections: Listed
  • 1% gels: Not listed (none found)
  • Oral capsules: Listed

Nova Scotia

  • Injections: Listed
  • 1% gels: Listed with conditions (exception status)
  • Oral capsules: Listed

New Brunswick

  • Injections: Listed
  • 1% gels: Listed with conditions (special authorization)
  • Oral capsules: Listed with conditions (special authorization)

Prince Edward Island

  • Injections: Listed
  • 1% gels: Listed with conditions (special authorization)
  • Oral capsules: Listed with conditions (special authorization, after injections fail)

Newfoundland and Labrador (30-day fills)

  • Injections: Listed (cypionate)
  • 1% gels: Not verified
  • Oral capsules: Listed with conditions (special authorization)

NIHB (First Nations, Inuit) and Northwest Territories

  • Injections: Listed
  • 1% gels: Listed with conditions (limited use)
  • Oral capsules: Listed

Veterans Affairs Canada

  • Injections: Listed with conditions (special authorization)
  • 1% gels: Listed with conditions (special authorization)
  • Oral capsules: Listed with conditions (special authorization)

Yukon and Nunavut (residents without NIHB)

  • Injections: Not verified
  • 1% gels: Not verified
  • Oral capsules: Not verified

Natesto, Jatenzo and Kyzatrex were not on any list we read. Checked September 2026. Plan membership rules differ; see each plan.

How each public drug plan lists the three main forms of testosterone: listed with no conditions, listed with conditions (limited use, special authority or exception status), not listed, or not verified. Natesto, Jatenzo and Kyzatrex were not on any list we read. Checked September 2026. Sources: Ontario Drug Benefit Formulary · BC PharmaCare formulary · RAMQ List of Medications · Alberta Drug Benefit List · NIHB Drug Benefit List.

Natesto, Jatenzo and Kyzatrex were not on any provincial or federal list we read. "Not listed" is not "never covered", though: plans such as NIHB consider unlisted products case by case. Some lists still show cancelled products (Delatestryl in Saskatchewan, Depo-Testosterone in Manitoba). National pharmacare does not help: the Pharmacare Act funds only contraception and diabetes medicines, and British Columbia's added menopause hormone therapy does not include testosterone for men. [51], [17], [10], [11], [6], [54], [55]

Does private insurance cover TRT?

Often, according to readers, but we found no official figures. Workplace drug plans set their own lists and rules. In public threads, readers describe plans paying all or most of a pharmacy-filled testosterone prescription, reimbursement that varied when a clinic dispensed the medicine, and a compounded cream their plan would not cover. Ask your insurer which product and DIN it covers before you fill the prescription. [22], [56], [57], [58]

Which testosterone products are available in Canada?

Eight products are marketed: one cypionate injection, one enanthate injection, three 1% gels, Natesto nasal gel and two oral capsules. Three more are approved but not yet on sale. Checked 28 September 2026 in Health Canada's Drug Product Database. [15]

ProductForm and strengthCanadian label starting doseStatus
Taro-Testosterone CypionateIntramuscular injection (into a muscle), 100 mg/mL, 10 mL vial200 mg every 2 weeks, up to 400 mg a monthMarketed; the only cypionate on sale
Testosterone enanthate (Hikma)Intramuscular injection, 200 mg/mL, 5 mL vial100–400 mg every 4 weeksMarketed since 30 January 2024
AndroGel 1%Transdermal gel (absorbed through the skin), 2.5 g and 5 g packets and a pump5 g (50 mg) daily, raised to 7.5 g and then 10 g if neededMarketed
Testim 1%Transdermal gel, 5 g tube (50 mg)See the product monographMarketed
Taro-Testosterone Gel 1%Transdermal gel, packetsSee the product monographMarketed; a pump version was approved on 18 September 2026 but is not yet marketed
NatestoIntranasal gel (into the nose), 4.5%11 mg twice daily (22 mg a day), three times daily if neededMarketed (first marketed May 2016; current status since 15 September 2022)
Taro-Testosterone oral undecanoateCapsule, 40 mg120–160 mg a day in two doses for 2–3 weeks, then 40–120 mg a day, with mealsMarketed
JatenzoOral undecanoate capsules, 158, 198 and 237 mg237 mg twice daily with foodMarketed since 24 April 2026
KyzatrexOral undecanoate capsules, 100, 150 and 200 mgNot yet marketedApproved 30 June and 2 July 2026
StériMax testosterone cypionateIntramuscular injection, 100 mg/mLSame as Taro'sApproved 20 July 2026, not yet marketed

[15], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69]

The product guides cover each form in depth: testosterone cypionate, enanthate, gels, Natesto and oral testosterone. These guides are for men; testosterone for women uses different products and doses, covered in testosterone therapy for women.

Check the strength before copying a volume from a US source. Canadian cypionate is 100 mg/mL, so 100 mg is 1 mL, or 100 units on a U-100 insulin syringe. US cypionate also comes at 200 mg/mL, where the same 100 mg is 0.5 mL. The TRT dose calculator does the conversion. [59], [70]

Which products are no longer sold in Canada?

  • Depo-Testosterone (cypionate): cancelled 18 July 2025. [15]
  • Delatestryl (enanthate): cancelled 18 December 2025. [15]
  • Andriol (oral undecanoate): cancelled 29 January 2018; Taro's 40 mg capsule remains. [15]
  • Androderm patch: cancelled in 2021 and 2022. Axiron solution: cancelled 4 December 2017. [15]
  • PMS-Testosterone oral capsule: dormant since 1 August 2025. [15]

Some products sold elsewhere have no Canadian product at all: Sustanon or any other mixed-ester injection, testosterone propionate for people, AndroGel 1.62%, testosterone pellets and the long-acting undecanoate injection. [16], [71], [15] Anything sold under those names in Canada is imported, compounded or unregulated.

Why do Canadians report testosterone shortages?

Because each injection has a single supplier. Only one company markets cypionate and one markets enanthate, so a supply problem at either leaves no same-ester backup until StériMax's approved cypionate reaches pharmacies. Readers reported pharmacy back orders of cypionate in Ontario in December 2025 and of enanthate in March 2026, with some switched to the other ester. [15], [72], [73]

What does TRT cost in Canada?

There is no single price. What you pay depends on your drug plan, your pharmacy's dispensing fee and whether you pay a clinic. Official drug-plan prices give a useful reference for the medicine itself. Checked September 2026.

ProductOntario Drug Benefit priceQuebec RAMQ list priceOther plans
Cypionate 100 mg/mL, 10 mL vial (Taro)$34.878$20.78Saskatchewan $34.88; Alberta and Nova Scotia $3.4878 per mL; Newfoundland and Labrador $3.8017 per mL; BC pays up to $3.88 per mL
Enanthate 200 mg/mL, 5 mL vial (Hikma)$35.5943$24.42Saskatchewan $7.119 per mL; Alberta $7.1189 per mL; Nova Scotia $9.708 per mL; BC pays up to $7.6884 per mL
1% gel, 5 g packetTaro $2.9575; Testim $4.4045; AndroGel listed at $4.5117, but the plan pays the Taro price30 packets: Taro $88.73, AndroGel $115.17Not listed in BC, Alberta or Saskatchewan
Oral undecanoate 40 mg (Taro)$0.5649 per capsule$33.89 for 60 capsulesSaskatchewan $0.5649 per capsule

[17], [7], [10], [9], [12], [18], [8]

These are prices the plans recognize for the drug, before the pharmacy's dispensing fee. As a worked example, a 10 mL vial of cypionate holds 1,000 mg, so at the Canadian label dose of 200 mg every 2 weeks it lasts 10 weeks: about $3.50 of medicine a week at Ontario's price. [17], [59]

What do you pay under a public drug plan?

Your share depends on the plan:

  • Ontario (seniors): the first $100 each program year (1 August to 31 July), then up to $6.11 per prescription; lower-income seniors pay no deductible and up to $2. [49]
  • Quebec (RAMQ public plan, 1 July 2026 to 30 June 2027): a $21.25 monthly deductible, then 30% of the cost up to a monthly maximum. [74]
  • British Columbia (Fair PharmaCare): an income-based deductible, then PharmaCare pays 70% (75% if a family member was born before 1940) until the family maximum, and 100% after that. Families who have not registered have a $10,000 deductible, and dispensing fees up to $11 count toward it. [75], [76]
  • Alberta (Non-Group Coverage for residents under 65): a monthly premium of $63.50 single or $118 family ($44.45 or $82.60 subsidized), then a 30% co-payment up to $35 per prescription since 1 April 2026. Seniors' coverage has no premium and the same co-payment. [77], [78]

Are the blood tests free?

Mostly, when an authorized practitioner orders them, with one important gap. In Ontario, total and free testosterone, estradiol, LH and FSH are insured tests. PSA is insured only for men diagnosed with, treated for or suspected of having prostate cancer, so routine PSA checks on TRT can be billed to you. British Columbia's medical plan does not pay for screening PSA tests. For scale, BC's protocol listed what its plan paid labs in 2022: $15.81 for total testosterone and $29.37 for bioavailable testosterone. Checked September 2026. [28], [79], [31]

What do clinics and cash prices cost?

No official source tracks them, so the figures below are reader reports from public forums between September 2025 and September 2026, not quotes. Readers described:

  • Online-clinic fees of about $49 to $430 every three months, or $150 to $350 a month on monthly plans. Yearly costs ranged from a renewal fee of about $680 to about $8,000 for one private program. [21], [22], [23], [80], [81]
  • Private hormone panels of about $150 to $300 or more, and a separate requisition fee of about $40 at one clinic. [82], [83], [84], [85]
  • Pharmacy cash prices for a 10 mL vial of cypionate 100 mg/mL of roughly $38 to $65, and much less with insurance. [19], [22], [20]

Prices change often, and clinic fees usually do not include the medicine.

What are the rules for testosterone in Canada?

Testosterone is a Schedule IV controlled substance under the Controlled Drugs and Substances Act: legal to have with a prescription, illegal to sell, import or export without authorization. Several rules change on 1 October 2026, when new Controlled Substances Regulations take effect. Checked September 2026. [1], [25]

Before-and-after comparison of four testosterone rules around 1 October 2026: the regulations that apply, the travel allowance (30 to 90 days), pharmacist extensions and transfers, and nurse practitioner prescribing, which does not change.

What changes for testosterone on 1 October 2026

When the new Controlled Substances Regulations take effect. Checked September 2026.

Regulations

Until 30 September 2026Food and Drug Regulations, Part G (controlled drug)

From 1 October 2026Controlled Substances Regulations (Schedule 2, Part 3)

Travel allowance

Until 30 September 2026The lesser of 30 days' supply or one course of treatment

From 1 October 2026Up to 90 days' supply, declared, in a pharmacy-labelled container showing the daily dose

Pharmacist extensions and transfers

Until 30 September 2026A temporary exemption, which expires on 30 September 2026

From 1 October 2026A pharmacist may extend or transfer a prescription within 2 years of receiving it

Nurse practitioners

Until 30 September 2026May prescribe testosterone (New Classes of Practitioners Regulations)

From 1 October 2026No change: may still prescribe testosterone and other controlled drugs their province authorizes

Unchanged: Schedule IV status; possessing your own supply is not an offence; ordering by mail from abroad is not allowed. Checked September 2026, before the change; Health Canada's traveller page still showed the 30-day rule.

What changes for testosterone when the Controlled Substances Regulations take effect on 1 October 2026: the regulations that apply, the travel allowance and pharmacist extensions and transfers. Nurse practitioner prescribing stays the same. Checked September 2026. Sources: Controlled Substances Regulations (SOR/2025-242) · Health Canada s.56 class exemption · Health Canada travel page.

Is testosterone legal in Canada?

Yes, with a prescription. Testosterone is a Schedule IV controlled substance. Simple possession of a Schedule IV drug is not an offence, because the possession offence covers only Schedules I to III. Trafficking, importing or exporting it without authorization is an offence, with up to 3 years in prison on indictment. [1]

Other countries treat it differently: the United States lists testosterone in Schedule III, the United Kingdom lists testosterone as a Class C drug, and Australia lists testosterone in Schedule 4 of its Poisons Standard. See the guides for the United States, the United Kingdom and Australia. [86], [87], [88]

What changes on 1 October 2026?

  • New regulations. Testosterone moves from Part G of the Food and Drug Regulations to the new Controlled Substances Regulations. [33], [25]
  • Pharmacists. A temporary exemption that let pharmacists extend, renew and transfer prescriptions for controlled drugs such as testosterone expires on 30 September 2026. The new regulations then let a pharmacist extend or transfer a prescription within 2 years of receiving it. [89], [25]
  • Travel. Until 30 September 2026, you may carry the lesser of 30 days' supply or one course of treatment. From 1 October 2026, you may carry up to 90 days' supply of your own testosterone, declared on entry and kept in a pharmacy-labelled container that shows the daily dose. Health Canada's traveller page still described the 30-day rule when we checked. [90], [25]
  • Nurse practitioners: no change. They can still prescribe testosterone and other controlled drugs their province authorizes. Midwives and podiatrists could not prescribe anabolic steroids such as testosterone before 1 October, and still cannot. [2], [25]

How do prescriptions, refills and transfers work?

The prescriber sets the number of refills, and a prescription can be written or given by phone. We found no general federal expiry date in either set of regulations. Provinces and plans add their own limits: Newfoundland and Labrador's drug program, for example, pays for no more than 30 days per fill. [33], [25], [18]

You can move a prescription to another pharmacy: under the temporary exemption until 30 September 2026, and under the new regulations after that. Readers describe moving prescriptions from clinic-linked pharmacies to local ones to use their insurance. [89], [25], [91]

Can you order testosterone online from another country?

No. The Canada Border Services Agency says an individual "cannot import or export controlled substances" by mail or courier without a permit or an exemption, and the traveller allowance covers only medicine you carry yourself. In a 2025 advisory about unauthorized products that "may pose serious health risks", Health Canada also notes that anabolic steroids "have a potential for abuse and dependence". [24], [25], [92]

Can you travel with testosterone to and from Canada?

Yes, within the limits above, in its pharmacy-labelled container. Other countries set their own rules; the traveling with testosterone guide covers destinations, time zones and storage. [90], [25]

Are compounded testosterone creams legal in Canada?

Yes, when a pharmacy makes them for a patient's prescription, but they are not Health Canada-approved products. Health Canada's policy says compounding should be done only for a therapeutic need or when a product is unavailable, "should not be done solely for economic reasons", and should not duplicate an approved product. Pharmacy compounding follows national model standards adopted by each province's pharmacy regulator. The CUA notes "significant variability" of testosterone concentrations in compounded products. [93], [94], [3] See compounded testosterone cream.

Is testosterone allowed in sport in Canada?

No. The World Anti-Doping Agency (WADA) prohibits testosterone at all times, and athletes with a medical need must apply for a therapeutic use exemption. National-level athletes apply through Canada's anti-doping program, run by the Canadian Centre for Ethics in Sport. Its 2026 checklist, issued under the Sport Integrity Canada name, grants exemptions only for organic causes, meaning a structural or genetic problem such as Klinefelter syndrome or pituitary disease. It asks for testosterone, LH, FSH and SHBG measured at least twice within four weeks, including a morning sample. International-level athletes must also meet their federation's rules. [27], [95], [96], [97]

Can you donate blood while on TRT in Canada?

Usually yes. Canadian Blood Services says taking hormone medicine does not on its own stop an otherwise eligible donor, and men wait 56 days between whole-blood donations. Checked September 2026. [98], [99] The hematocrit on TRT guide explains when donation helps and when it does not.

Is TRT safe, and what does Health Canada say?

Is TRT safe?

For men with confirmed low testosterone who are monitored, the largest safety trial found testosterone was not worse than placebo for heart attacks, strokes and cardiovascular deaths. Some other problems were more common, and long-term data are limited. [100]

In TRAVERSE, 5,204 men aged 45 to 80 with low testosterone and existing heart disease or high heart risk used testosterone gel or placebo gel. Heart attack, stroke or cardiovascular death occurred in 182 of 2,596 men on testosterone (7.0%) and 190 of 2,602 on placebo (7.3%). The hazard ratio was 0.96, which met the trial's test for being no worse than placebo (noninferior). In the same 2,596 and 2,602 men, atrial fibrillation (3.5% vs 2.4%), acute kidney injury (2.3% vs 1.5%) and pulmonary embolism (0.9% vs 0.5%) were more common on testosterone. Fractures were also more common: 91 of 2,601 men (3.5%) vs 64 of 2,603 (2.5%). [100], [101], [102]

Its limits matter: it tested only a daily gel, men used it for an average of 21.7 months, about 61% stopped their study gel early, and everyone was already at high heart risk. [100], [101] The TRT and heart health guide covers the trial in full, and TRT side effects covers the everyday ones.

What has Health Canada said about testosterone safety?

  • 2014 review. Health Canada reviewed 35 Canadian reports of heart and blood-vessel problems; in 11, a heart attack, lung clot or irregular heart rate was considered possibly related to testosterone. Health Canada said it was working with manufacturers to add these possible risks to Canadian labels. This review predates TRAVERSE. [103]
  • 2026 review. In May 2026, prompted by the US Food and Drug Administration, Health Canada started a review of testosterone products "reassessing prostate cancer risk". A review is not a finding, and no Canadian label change had been announced when we checked in September 2026. [26] For context, TRAVERSE found high-grade prostate cancer in 5 of 2,596 men on testosterone and 3 of 2,602 on placebo. That difference was not statistically significant, and men with a PSA above 3.0 ng/mL were not enrolled. [104] The TRT and prostate guide covers this in full.
  • Labels keep changing. The Taro gel monograph was revised on 25 March 2026, including its heart and blood-vessel warnings, and warns that "testosterone may increase blood pressure". [63]

Who should be especially cautious?

  • Men who want children soon. Testosterone suppresses sperm production; the CUA lists a wish to preserve fertility as a reason not to use it and names alternatives. See TRT and fertility and the hCG guide. [3]
  • Men with known or suspected breast cancer, or metastatic or high-risk prostate cancer likely to need hormone-blocking treatment, and men with unstable heart disease: the CUA lists these as contraindications (reasons not to use it). [3]
  • Men with a high hematocrit, untreated severe sleep apnea or a clotting disorder. The CUA acts when hematocrit stays at 55% or higher on treatment. The Endocrine Society lists a raised hematocrit, untreated severe sleep apnea and thrombophilia (an inherited or acquired tendency to form clots) among reasons not to start. [3], [105] See hematocrit on TRT.
  • Drug-tested athletes. Banned at all times. [27]
  • Under-18s. Testosterone for teenagers is specialist care only.
  • Women. This guide is for men; see testosterone therapy for women.

Can TRT be taken with other medicines?

Yes, with checks. The Canadian monograph for Taro's testosterone gel (revised March 2026) lists three main interactions. Insulin and other diabetes medicines may need lower doses. Oral blood thinners such as warfarin need more frequent clotting tests. Corticosteroids can add to fluid build-up. It also notes faster clearance of the heart medicine propranolol with injected testosterone, and that St John's wort may lower testosterone levels. [63] The practical step is simple: bring a full list of everything you take, including supplements, to your pharmacist or prescriber when you start.

What follow-up does TRT need in Canada?

The CUA checks symptoms, testosterone and PSA at 3 and 6 months and then yearly, and hematocrit at 3 months and then yearly. British Columbia's protocol is similar. Use this summary to prepare questions for your prescriber; it is not a personal testing plan. [3], [31]

What is checkedCUA (2021)British Columbia protocol (2022)
SymptomsBefore starting, 3 and 6 months, then yearly; stop if no clinical improvement after about 3 months despite normal levelsNot stated separately
TestosteroneBefore starting, 3 and 6 months, then yearly; aim for mid-normal, 14–17 nmol/L (404–490 ng/dL), measured mid-cycle for injectionsYearly once stable; injections drawn mid-interval or at the trough, gel or nasal gel 2–8 hours after a dose, oral capsules 3–5 hours after a fatty meal
HematocritBefore starting, 3 months, then yearly; act at 55% or higher if it persists3 and 6 months, then yearly
PSABefore starting, 3 and 6 months, then yearly3 and 6 months, then yearly
Digital rectal examBefore starting, then yearly3 and 6 months, then yearly

[3], [31]

The CUA's hematocrit line (55%) is one point higher than the 54% used by the American Urological Association and the Endocrine Society. [3], [46], [105] See hematocrit on TRT and TRT blood work.

The CUA expects changes in sex drive, energy and sexual function after 3 months or longer, and changes in body composition and bone after 6 months or more. [3] See the TRT results timeline.

Plan for the PSA gap. Because Ontario pays for PSA only in prostate-cancer situations, and British Columbia does not pay for screening PSA, ask your prescriber whether your monitoring PSA will be billed to you. [28], [79]

What do Canadians on TRT report?

The accounts below come from public Reddit threads by Canadians, posted between September 2025 and September 2026, read with their replies and described without identifying anyone. They show what people experience, not how often it happens.

Why do family doctors say no?

Often because of the number. One man in his 30s was declined at 10.5 nmol/L and asked whether results below 8 nmol/L on two tests were a legal requirement; they are not, but some clinicians use a cut-off like that. Another had three falling results over a year (8, 7.5 and 6.8 nmol/L) and was told they were within range. A man in his 40s with a 9.7 nmol/L result turned to an online clinic after his doctor did not follow up. Replies urged fresh morning labs and a sleep check, and he said treatment for sleep apnea had helped somewhat. [106], [107], [108]

Others had the opposite experience. A man in his 50s received a trial of 1% gel from his family doctor after two low readings, and another got AndroGel after repeat testing (13.9 and 11.8 nmol/L), fully paid by his drug insurance. He later rubbed part of a higher dose onto an unapproved site and his level jumped to 30.2 nmol/L, a reminder that where gel goes changes the result. [109], [56]

Online clinics decline people too. One advised a man with a reported total testosterone of 8.2 to work on his sleep and retest in a year. Another approved treatment but advised a man in his 30s who wanted children to wait, and offered hCG instead. [110], [111]

What do people report about waits for specialists?

Long waits, and sometimes risky shortcuts. A man in his 20s with a total testosterone of 4.7 nmol/L feared a six-month to one-year wait for an endocrinologist. In Manitoba, one man facing a roughly six-month wait for a men's health clinic bought an unprescribed injectable blend but had not used it; replies warned against starting before the assessment. Another began self-treatment while waiting, briefly felt better, then developed acne and stopped after a few months. In Quebec, one reader reported a private urology appointment within two weeks after a long public wait. [112], [113], [114], [115]

How hard is it to get blood work?

It depends on the province and on having a doctor. One reader in Saskatchewan with no family doctor found that a walk-in doctor would not order labs and private labs required a requisition. A commenter in New Brunswick said a locally licensed doctor had to sign his requisition. A man in Nova Scotia on an online clinic's prescription described a long drive and weeks of delay for his follow-up blood test. [44], [45], [116]

What do people say about costs and insurance?

Fees vary widely. One man paying about $350 a month switched to a clinic that charged $49 for a consultation, accepted his recent labs and sent the prescription to his chosen pharmacy. Two vials cost him about $76 before insurance and $3.99 after it. Another faced a $678 annual renewal. One man paid about $8,000 a year for a private program, felt poorly on the 100 mg a week he was prescribed and then raised the dose himself. [22], [80], [81]

When fees rose, some turned to unregulated sources. One man left a clinic charging $150 a month and felt fine on underground testosterone for a while. Then he used a vial he believed was fake, his testosterone fell to 6.1 nmol/L and his symptoms returned. He noted that a pharmacy vial would have cost him about $65. [23], [20]

What goes wrong at the pharmacy?

Supply and paperwork. Readers described cypionate and enanthate back orders, with some switched to the other ester or to a compounded product. One man worried that a new vial of the only marketed cypionate was weaker; replies thought a defective vial unlikely and suggested a repeat test. One online prescriber required patients to return old vials before each refill, which other Canadians had never been asked to do. [72], [73], [117], [118]

How can you judge a Canadian TRT story?

Ask: Which province, and which route (family doctor, specialist or clinic)? Was the blood drawn in the morning, and was it total or free testosterone, in nmol/L or ng/dL? What did a fee include: the visit, the labs, the medicine? Was the product a Health Canada-approved one filled at a pharmacy? And when was it posted, since prices and rules, including the 1 October 2026 changes, keep moving?

These selected discussions show what people experience and which questions Canadians struggle with. They are not a survey of all Canadians on TRT, a success rate or a substitute for the guidelines and rules above.

Common questions about TRT in Canada

Is TRT legal in Canada?

Yes, with a prescription. Testosterone is a Schedule IV controlled substance, which means doctors and nurse practitioners can prescribe it and pharmacies can dispense it. Having your own prescribed supply is legal, and even simple possession of a Schedule IV drug is not an offence; selling it, or importing it by mail from abroad, is. [1], [24] See the rules.

Does provincial insurance cover TRT?

Partly. Visits and most lab tests are covered when an authorized practitioner orders them, though routine PSA checks may not be. For the medicine, every provincial plan we read lists testosterone injections, some with conditions. Gels are covered with conditions in Ontario, Nova Scotia, New Brunswick and Prince Edward Island, and without conditions in Quebec. They are not on the lists for British Columbia, Alberta, Saskatchewan or Manitoba. Ontario pays only for a named medical cause. Checked September 2026. [28], [5], [7], [8], [9], [10], [11] See coverage by province.

How much does TRT cost in Canada without insurance?

The medicine itself is fairly cheap. Readers paying cash at a pharmacy in 2025–2026 reported about $38 to $65 for a 10 mL vial of cypionate, and a vial lasts 10 weeks at the Canadian label dose. For reference, drug-plan list prices for the same vial run from $20.78 to about $39 before the pharmacy fee. Online-clinic fees come on top: readers reported about $49 to $430 every three months, or $150 to $350 a month. Checked September 2026. [19], [22], [20], [59], [7], [18], [8], [21], [23] See what TRT costs.

Can I get TRT from an online clinic in another province?

It depends on where you live. Ontario and Alberta generally require the prescribing doctor to be registered in the province, and Quebec requires a Quebec permit for regular care. British Columbia lets a doctor licensed elsewhere treat BC patients virtually. Checked September 2026. [29], [36], [37], [39] See virtual care.

What testosterone level do you need for TRT in Canada?

There is no legal cut-off. The CUA treats total testosterone below 10 nmol/L (288 ng/dL), drawn between 7 and 11 am, as a reasonable threshold in a man with symptoms. British Columbia's protocol uses each lab's lower limit, about 6 to 8 nmol/L depending on age. Choosing Wisely Canada says to confirm a low result on another day. [3], [31], [4] See the thresholds.

Is Natesto available in Canada?

Yes. Natesto nasal gel was first marketed in Canada in May 2016, and Health Canada's database lists it as marketed (status dated 15 September 2022). Older statements that it was unavailable are out of date. It was not on any public drug-plan list we read, so check with your plan or insurer before filling it. The Canadian label starts at 11 mg twice daily. [15], [65], [17] See the Natesto guide.

Is Depo-Testosterone still available in Canada?

No. Depo-Testosterone was cancelled in Canada on 18 July 2025. Taro's testosterone cypionate, at 100 mg/mL, is the only cypionate on sale, and a StériMax cypionate was approved in July 2026 but is not yet marketed. [15], [69] See the product list.

How is Canada's Schedule IV different from the US Schedule III?

Both control testosterone, but differently. In Canada, possessing a Schedule IV drug without a prescription is not an offence, while importing, exporting or selling it is. In the United States, testosterone is a Schedule III controlled substance under federal drug law, and the US guide explains what that means for prescriptions and telehealth. [1], [86] See the US guide.

Glossary

Plain explanations of the medical, insurance and legal terms used in this guide. Underlined terms in the text link here.

Atrial fibrillation
An irregular, often fast heart rhythm. It can cause palpitations and raises the risk of stroke.
Bioavailable testosterone (cBAT)
The part of testosterone in the blood that is free or loosely bound, and so available to the body. Labs calculate it (cBAT) from total testosterone, SHBG and albumin; it is used when total testosterone is borderline.
Co-payment and co-insurance
The share of each prescription you pay after any deductible. A co-payment may be a fixed amount or a percentage with a cap, such as Alberta's 30% up to $35.
Compounding
A pharmacy preparing a medicine for one patient's prescription, such as a testosterone cream. Compounded products are not approved or given a DIN by Health Canada.
Controlled substance
A drug whose prescribing, possession, import or export is restricted by drug law. In Canada, testosterone is a Schedule IV controlled substance.
CUA
The Canadian Urological Association, whose 2021 guideline is Canada's main clinical guideline on testosterone deficiency in men.
Deductible
The amount you pay for prescriptions before a drug plan starts paying, for example Ontario's $100 a year for seniors or Quebec's $21.25 a month.
Digital rectal exam (DRE)
A quick physical check of the prostate by a clinician, using a gloved finger.
DIN (Drug Identification Number)
The eight-digit number Health Canada gives each approved drug product. Drug plans list coverage by DIN.
Dispensing fee
The pharmacy's charge for filling a prescription, added to the price of the drug. Drug-plan list prices do not include it.
Formulary (drug benefit list)
The list of drugs a drug plan pays for, with any conditions and the price it recognizes.
FSH (follicle-stimulating hormone)
A pituitary hormone that drives sperm production in the testes. It is often measured with LH to find the cause of low testosterone.
Hazard ratio
A way trials compare how often an event happens in two groups over time. A hazard ratio of 1 means no difference; 0.96 means slightly fewer events in the treated group, a gap small enough to be chance.
Hematocrit
The share of the blood made up of red blood cells. Testosterone can raise it, which is why it is checked.
Hemochromatosis
An inherited condition in which the body stores too much iron. Iron build-up can damage the pituitary gland or testes and lower testosterone.
Hypogonadism (testosterone deficiency)
Low testosterone caused by a problem in the testes or in the brain signals that control them, usually confirmed by symptoms and low morning blood tests.
Intramuscular (IM)
Injected into a muscle. Testosterone cypionate and enanthate are labelled for this route.
Intranasal
Applied inside the nose and absorbed through its lining, as with Natesto.
Klinefelter syndrome
A genetic condition in which a male is born with an extra X chromosome (XXY). It is a common cause of primary hypogonadism.
LH (luteinizing hormone)
A pituitary hormone that tells the testes to make testosterone. A high LH with low testosterone points to primary hypogonadism; a low or normal LH points to secondary.
Limited Use
Ontario's term for a drug the public plan covers only when the prescriber writes a reason-for-use code showing the patient meets set criteria.
NIHB
The federal Non-Insured Health Benefits program, which pays for medicines for eligible First Nations and Inuit people anywhere in Canada.
Nurse practitioner
A registered nurse with advanced training who can diagnose, order tests and prescribe, including controlled drugs, within provincial rules.
Primary hypogonadism
Low testosterone because the testes themselves do not work properly, for example after injury or in Klinefelter syndrome.
Product monograph
The official Canadian document for an approved medicine, describing its uses, doses, warnings and storage. It is Canada's equivalent of a US label.
Prolactin
A pituitary hormone. A high level can switch off the signal to make testosterone and may point to a pituitary problem.
PSA (prostate-specific antigen)
A protein made by the prostate, measured in a blood test. Guidelines check it before and during TRT to watch for prostate problems.
Pulmonary embolism
A blood clot that travels to the lungs and blocks blood flow there. It is a medical emergency.
Requisition
A practitioner's written order for lab tests. Public insurance pays for insured tests only when an authorized practitioner signs it.
Secondary hypogonadism
Low testosterone because the pituitary gland or hypothalamus does not send enough signal to the testes.
SHBG (sex hormone-binding globulin)
A protein in the blood that binds testosterone tightly. Labs use it with total testosterone to estimate free or bioavailable testosterone.
Special authorization (Special Authority)
A drug-plan process in which the prescriber applies for coverage for a specific patient who meets set criteria. British Columbia calls it Special Authority.
Therapeutic use exemption (TUE)
Permission from an anti-doping organization for an athlete to use a banned medicine for a genuine medical need.
Transdermal
Absorbed through the skin, as with testosterone gels.
TRT (testosterone replacement therapy)
Prescribed testosterone, by injection, gel or other forms, for men with low testosterone.
Virtual care (telehealth)
Care by video, phone or messaging instead of in person. Provincial medical colleges set the rules for doctors who provide it.
WADA
The World Anti-Doping Agency, which publishes the list of substances banned in sport. Testosterone is prohibited at all times.

How this guide was researched

This guide is built from a thorough review of the sources cited throughout it: federal laws and regulations, Health Canada's drug database and product monographs, provincial and federal drug-plan formularies, medical college standards, Canadian clinical guidelines and published research. We also reviewed public online forums where Canadians describe getting and paying for TRT.

The guide cites 118 sources, including 76 laws, regulator and drug-plan documents, product labels and other official rules, 7 clinical guidelines and reviews, 3 clinical trials and 32 public community discussions. Each type of source answers a different question. Laws and drug plans show the rules and prices. Guidelines show what Canadian doctors are advised to do. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labelled by source type.

How this guide was made

Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.

This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical, legal or insurance advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.

Explore the sources

These are the documents cited in this guide. Laws, regulators, drug plans, guidelines, studies and personal accounts answer different questions. A source being listed does not mean every statement on its page is endorsed.

Showing 118 sources

  1. 01

    Controlled Drugs and Substances Act (S.C. 1996, c. 19) ↗

    Law (Canada)

    Official text reviewed (ss. 4, 5, 6 and Schedule IV).

    Detail: Anabolic steroids, including testosterone, are in Schedule IV. The possession offence in s. 4(1) covers Schedules I to III only; s. 4(2) requires disclosure of other prescriptions from the previous 30 days; trafficking and import or export of Schedule IV carry up to 3 years on indictment.

  2. 02

    New Classes of Practitioners Regulations (SOR/2012-230) ↗

    Regulation (Canada)

    Official text reviewed.

    Detail: Section 4(2)(a) excludes anabolic steroids from what nurse practitioners may prescribe "except for subitem (40)", testosterone.

  3. 03

    Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A ↗

    Clinical guideline (Canada)

    Full text reviewed.

    Detail: Morning total testosterone (7–11 am); below 10 nmol/L a reasonable threshold; LH for all, prolactin if secondary; target 14–17 nmol/L; act at hematocrit 55% or more; monitoring at baseline, 3, 6 months and yearly; stop if no benefit after about 3 months; compounded products vary in concentration.

  4. 04

    Endocrinology and Metabolism: Canadian Society of Endocrinology and Metabolism recommendations ↗

    Clinical recommendation (Canada)

    Live page reviewed (September 2026).

    Detail: "Don't prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency"; confirm a low morning total testosterone on a different day.

  5. 05

    Ontario Drug Benefit Formulary: Limited Use notes for testosterone (reason for use code 397) ↗

    Drug plan criteria (Ontario)

    Official criteria reviewed.

    Detail: "Confirmed low morning serum testosterone levels associated with documented, symptomatic hypothalamic, pituitary or testicular disease, or in HIV-infected patients"; 1-year authorization; older men with nonspecific symptoms and a low-normal random level do not qualify.

  6. 06

    Pharmacare Act (S.C. 2024, c. 24) ↗

    Law (Canada)

    Official text reviewed.

    Detail: Section 6(1) funds coverage only for drugs "intended for contraception or the treatment of diabetes".

  7. 07

    List of Medications (27 August 2026 edition) ↗

    Drug plan formulary (Quebec)

    Full list reviewed from an archived copy of the publisher PDF; later editions not reviewed.

    Detail: Gels, cypionate, enanthate and oral undecanoate in the regular section. Prices: cypionate 10 mL $20.78, enanthate 5 mL $24.42, Taro gel 5 g x30 $88.73, AndroGel 5 g x30 $115.17, oral undecanoate x60 $33.89.

  8. 08

    BC PharmaCare Formulary Search: testosterone ↗

    Drug plan formulary (British Columbia)

    Official search results reviewed.

    Detail: Three products shown: cypionate (up to $3.88 per mL) and enanthate (up to $7.6884 per mL) with Special Authority and up to 100 days per fill; oral undecanoate with no price. Gels, Natesto, Jatenzo and Kyzatrex do not appear.

  9. 09

    Alberta Drug Benefit List (effective April 1, 2026) ↗

    Drug plan formulary (Alberta)

    Full list reviewed.

    Detail: Cypionate ($3.4878 per mL) and enanthate ($7.1189 per mL) listed; oral undecanoate by special authorization, not for age-related decline, 6-month approvals; gels not listed.

  10. 10

    Saskatchewan Online Formulary: testosterone records; Appendix A Exception Drug Status ↗

    Drug plan formulary (Saskatchewan)

    Official records and appendix reviewed.

    Detail: Regular benefits: cypionate $34.88 per 10 mL vial, enanthate $7.119 per mL, oral undecanoate $0.5649 per capsule (and cancelled Delatestryl). No gel listed.

  11. 11

    Manitoba Drug Benefits Formulary ↗

    Drug plan formulary (Manitoba)

    Full formulary reviewed.

    Detail: Part 1 lists Taro oral undecanoate, Taro cypionate and Hikma enanthate (and the cancelled Depo-Testosterone); no gel found.

  12. 12

    Nova Scotia Formulary (September 2026) ↗

    Drug plan formulary (Nova Scotia)

    Full formulary reviewed.

    Detail: Injections and oral undecanoate listed (cypionate $3.4878 per mL, enanthate $9.708 per mL); gels by exception with two biochemical tests, up to 5 g a day.

  13. 13

    New Brunswick Drug Plans Formulary and Special Authorization Criteria ↗

    Drug plan formulary (New Brunswick)

    Full formulary reviewed.

    Detail: Injections open; gels and oral undecanoate by Special Authorization, confirmed "by two separate free testosterone measurements"; gel up to 5 g daily; older men with nonspecific symptoms excluded.

  14. 14

    PEI Pharmacare Formulary (September 2026) ↗

    Drug plan formulary (Prince Edward Island)

    Full formulary reviewed.

    Detail: Injections listed for several programs; gels (two biochemical tests, 5 g a day) and oral undecanoate (after injections fail) by Special Authorization.

  15. 15

    Drug Product Database: human testosterone products and current status ↗

    Regulator database (Canada)

    Official structured records reviewed.

    Detail: Marketed: AndroGel, Testim, Natesto, Taro gel, Taro oral undecanoate, Taro cypionate, Hikma enanthate, Jatenzo (24 Apr 2026); Natesto first marketed 6 May 2016, current status dated 15 Sep 2022. Approved, not marketed: Kyzatrex, StériMax cypionate, Taro gel pump. Cancelled: Depo-Testosterone (18 Jul 2025), Delatestryl (18 Dec 2025), Andriol (29 Jan 2018), Androderm, Axiron. No pellet product.

  16. 16

    Drug Product Database queries: Sustanon; testosterone decanoate, isocaproate and phenylpropionate ↗

    Regulator database (Canada)

    Official structured records reviewed.

    Detail: No Sustanon product and no product containing the other Sustanon esters.

  17. 17

    Ontario Drug Benefit Formulary: testosterone ↗

    Drug plan formulary (Ontario)

    Official search results reviewed.

    Detail: All listed testosterone products are Limited Use. Prices: Taro cypionate 10 mL $34.878, Hikma enanthate 5 mL $35.5943, Taro gel 5 g $2.9575, Testim 5 g $4.4045, AndroGel 5 g $4.5117, oral undecanoate 40 mg $0.5649. Natesto and Jatenzo not listed.

  18. 18

    NLPDP Drug Product Database: Taro-Testosterone Cypionate and Taro-Testosterone 40 mg ↗

    Drug plan records (Newfoundland and Labrador)

    Official records reviewed.

    Detail: Cypionate open benefit ($3.8017 per mL); oral undecanoate by special authorization; fills limited to 30 days.

  19. 19

    My experience with my doctor in Canada, looking for advice ↗

    Community account

    Public thread reviewed: opening post and 13 comments.

    Detail: A commenter paid about $40 for a 10 mL vial of cypionate 100 mg/mL.

  20. 20

    Bought (and used) fake UGL testosterone for ~1 month ↗

    Community account

    Public thread reviewed: opening post and 8 comments.

    Detail: After a suspected counterfeit vial, the poster noted a pharmacy vial would cost about $65.

  21. 21

    Trt in Canada. So many options now... ↗

    Community account

    Public thread reviewed: opening post and 21 comments.

    Detail: Ontario commenters compared clinic fees from about $49 to $430 a quarter and a pharmacy price near $42.

  22. 22

    My experience switching TRT providers in Canada (cost, process, and first impressions) ↗

    Community account

    Public thread reviewed: opening post and 13 comments.

    Detail: After paying about $350 a month, the poster switched to a $49 consultation; two vials cost about $76 before insurance and $3.99 after.

  23. 23

    Why won’t Canadian doctors prescribe test? ↗

    Community account

    Public thread reviewed: opening post and 43 comments.

    Detail: After a clinic fee rose to $150 a month and a suspected counterfeit vial, the poster's testosterone fell to 6.1 nmol/L.

  24. 24

    Memorandum D19-9-2: Importation and Exportation of Cannabis, Controlled Substances and Precursors ↗

    Regulator guidance (Canada)

    Full document reviewed.

    Detail: "An individual cannot import or export controlled substances or precursors listed in Schedules I through VI by mail or by courier without a valid permit, or an exemption."

  25. 25

    Controlled Substances Regulations (SOR/2025-242) ↗

    Regulation (Canada)

    Official text reviewed.

    Detail: From 1 October 2026 testosterone is in Schedule 2, Part 3. Pharmacists may extend or transfer a prescription within 2 years of receiving it (ss. 101–102); travellers may carry up to 90 days' supply, declared and in a labelled container (s. 225); nurse practitioners may prescribe within provincial authorization (ss. 1(3), 153); midwives and podiatrists may not prescribe anabolic steroids (s. 154).

  26. 26

    New safety and effectiveness reviews (MedEffect Canada) ↗

    Regulator page (Canada)

    Live page reviewed (September 2026).

    Detail: Lists a review of testosterone replacement therapies, initiated May 2026 and triggered by the US FDA: "Reassessing prostate cancer risk".

  27. 27

    World Anti-Doping Code International Standard: Prohibited List 2026 ↗

    Anti-doping list

    Full list reviewed.

    Detail: Testosterone is prohibited at all times (S1.1).

  28. 28

    Schedule of Benefits for Laboratory Services (effective April 1, 2026) ↗

    Insurance schedule (Ontario)

    Full schedule reviewed.

    Detail: Only authorized practitioners may order insured tests; requisitions valid 6 months; testosterone, free testosterone, estradiol, LH and FSH are insured; PSA only for diagnosed, treated or suspected prostate cancer.

  29. 29

    Virtual Care (policy) ↗

    Medical college policy (Ontario)

    Full policy reviewed.

    Detail: Physicians caring for patients in Ontario must hold CPSO registration unless care is not readily available in Ontario, bridges an existing relationship, or is urgent; virtual care must meet the in-person standard.

  30. 30

    Urology: Canadian Urological Association recommendations ↗

    Clinical recommendation (Canada)

    Live page reviewed (September 2026).

    Detail: Do not order testosterone tests in men without symptoms; do not prescribe testosterone for erectile dysfunction when levels are normal.

  31. 31

    Testosterone Testing: Protocol (BC Guidelines) ↗

    Provincial guideline (Canada)

    Full protocol reviewed.

    Detail: Test only men with symptoms, before 10 am or within 3 hours of waking; lab lower limits about 8 nmol/L under 30 and 6 nmol/L over 50; hematocrit, PSA and rectal exam at 3 and 6 months then yearly; MSP lab fees current to April 2022.

  32. 32

    Wait times: Endocrinology ↗

    Provincial data (Nova Scotia)

    Official page reviewed.

    Detail: Halifax Ambulatory Care Clinic: 50th percentile 70 days, 90th percentile 318 days, from referral received to appointment.

  33. 33

    Food and Drug Regulations (C.R.C., c. 870), Part G and its schedule ↗

    Regulation (Canada)

    Official text reviewed.

    Detail: Until 30 September 2026, testosterone is a 'controlled drug' under Part G (schedule Part III); prescriptions may be written or verbal and refilled as the prescriber directs (G.03.002, G.03.006).

  34. 34

    Limited coverage criteria: testosterone injection (Special Authority) ↗

    Drug plan criteria (British Columbia)

    Official page reviewed.

    Detail: Special Authority for listed diagnoses, including hypogonadism, orchiectomy, undescended testes, Klinefelter syndrome and pituitary tumour or removal; indefinite approval.

  35. 35

    FMRAC Framework on Telemedicine ↗

    Regulator framework (Canada)

    Live page reviewed (September 2026).

    Detail: Physicians must comply with licensing requirements where the patient is located and assess before prescribing.

  36. 36

    Virtual Care Standard of Practice ↗

    Medical college standard (Alberta)

    Full standard reviewed.

    Detail: CPSA registration required, with exceptions; opioids and other "controlled medications" only after an in-person exam, within a longitudinal relationship, or in contact with a professional who examined the patient.

  37. 37

    Autorisation spéciale : télémédecine et autres ↗

    Medical college page (Quebec)

    Official page reviewed (in French).

    Detail: Physicians from elsewhere providing regular care to Quebec patients need a CMQ permit; special telemedicine authorization is the exception.

  38. 38

    Fiche 10 : prescription de médicaments (téléconsultation) ↗

    Medical college guidance (Quebec)

    Full document reviewed (in French).

    Detail: Special teleconsultation rules for narcotics, benzodiazepines and psychostimulants; testosterone is not named.

  39. 39

    Practice Standard: Virtual Care (version 9.3) ↗

    Medical college standard (British Columbia)

    Full standard reviewed.

    Detail: Physicians outside BC with an active licence elsewhere do not need a BC licence, cannot access PharmaNet, and should "exercise caution" prescribing for patients they have not examined.

  40. 40

    Monitored Drugs List: summary of changes (effective November 20, 2020) ↗

    Provincial list (Ontario)

    Full document reviewed.

    Detail: Adds Taro testosterone cypionate (DIN 02496003) to Ontario's Monitored Drugs List, whose dispensing is reported to the Narcotics Monitoring System. The current full list was not reviewed, so the guide names only this addition.

  41. 41

    Controlled Prescription Program; Prescription Regulations table ↗

    Pharmacy regulator page (British Columbia)

    Official page and table reviewed.

    Detail: Anabolic steroids do not need a Controlled Prescription Program form; testosterone products are federal Part 3 controlled drugs for pharmacy records.

  42. 42

    TPP Alberta: List of Monitored Medications (February 2026) ↗

    Provincial list (Alberta)

    Full list reviewed.

    Detail: Testosterone is not on the Type 1 or Type 2 monitored lists.

  43. 43

    Updates to Bioavailable Testosterone and Free Testosterone (lab bulletin) ↗

    Laboratory bulletin (Alberta)

    Full bulletin reviewed.

    Detail: Bioavailable testosterone was historically patient-pay; those criteria were removed.

  44. 44

    How do you get bloodwork requisitions in Canada without a family doctor or clinic? ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: In Saskatchewan, with no family doctor, a walk-in doctor would not order labs and private labs needed a requisition.

  45. 45

    Test levels in Canada ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: A New Brunswick commenter said a locally licensed doctor had to sign the lab requisition.

  46. 46

    Evaluation and Management of Testosterone Deficiency: AUA Guideline ↗

    Clinical guideline (US)

    Full guideline reviewed.

    Detail: Below 300 ng/dL on two early-morning tests; intervene at hematocrit 54% or higher.

  47. 47

    Testosterone supplementation for men (Tools for Practice) ↗

    Evidence review (Canada)

    Full text reviewed.

    Detail: In healthy older men or age-related low testosterone: about 1.6 kg more lean mass, no consistent meaningful effect on sexual function, strength, fatigue or cognition.

  48. 48

    NIHB Drug Benefit List: testosterone ↗

    Federal drug plan formulary

    Official online list reviewed.

    Detail: Cypionate, enanthate and oral undecanoate open benefits in all 13 provinces and territories; gels limited use; "Older individuals with non-specific symptoms ... who have a low random testosterone level do not meet coverage criteria."

  49. 49

    Get coverage for prescription drugs (Ontario Drug Benefit program) ↗

    Drug plan page (Ontario)

    Official page reviewed.

    Detail: Eligibility (65 and over; 24 and under without private insurance through OHIP+; social assistance; Trillium); seniors pay $100 a year then up to $6.11 per prescription, or up to $2 with no deductible on the Seniors Co-Payment Program.

  50. 50

    Get help with high prescription drug costs (Trillium Drug Program) ↗

    Government page (Ontario)

    Live page reviewed (September 2026).

    Detail: Helps Ontarians whose prescription-drug costs are high compared with household income, generally about 4% or more of after-tax household income.

  51. 51

    NIHB Program for First Nations and Inuit: Pharmacy Benefits Guide ↗

    Federal drug plan guide

    Official page reviewed.

    Detail: Defines open benefits, limited-use benefits and exception products that may be approved case by case.

  52. 52

    NT Pharmacare Formulary (Extended Health Benefits) ↗

    Drug plan formulary (Northwest Territories)

    Official page reviewed.

    Detail: Covers eligible drugs on the NIHB Drug Benefit List, with listed exclusions that do not include testosterone.

  53. 53

    Veterans Affairs Canada prescription drug formulary: Taro-Testosterone Cypionate ↗

    Federal drug plan formulary

    Official records reviewed.

    Detail: "This is not a Standard Benefit. Special Authorization is required."

  54. 54

    National pharmacare bilateral agreements ↗

    Government page (Canada)

    Live page reviewed (September 2026).

    Detail: Agreements with British Columbia, Manitoba, Prince Edward Island and Yukon cover contraception and diabetes medicines and supplies.

  55. 55

    Canada-British Columbia national pharmacare funding agreement ↗

    Government agreement (Canada)

    Live page reviewed (September 2026).

    Detail: From 1 March 2026, British Columbia adds free coverage of hormone therapy for menopausal symptoms; nothing for testosterone in men.

  56. 56

    My experience starting TRT using gel ↗

    Community account

    Public thread reviewed: opening post and 4 comments.

    Detail: A family doctor prescribed AndroGel after repeat testing; drug insurance paid in full. Applying gel to an unapproved site raised his level to 30.2 nmol/L.

  57. 57

    Canadian TRT clinics – quarterly follow up process ↗

    Community account

    Public thread reviewed: opening post and 13 comments.

    Detail: Commenters described quarterly requisitions and insurance reimbursement that varied for a quarterly clinic bill.

  58. 58

    How to get over hesitancy to start TRT ↗

    Community account

    Public thread reviewed: opening post and 33 comments.

    Detail: A family doctor prescribed cream; the poster said a clinic's compounded alternative was not covered by his insurance.

  59. 59

    Taro-Testosterone Cypionate Injection 100 mg/mL: product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: 200 mg intramuscularly every two weeks, maximum 400 mg a month; discard the vial 56 days after first use.

  60. 60

    Testosterone enanthate injection USP 200 mg/mL (Hikma Canada): product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Usually 100–400 mg every four weeks.

  61. 61

    AndroGel 1% (testosterone gel) sachets and pump: product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: 5 g (50 mg) daily, increased to 7.5 g and then 10 g if needed.

  62. 62

    Testim 1% (testosterone gel) 5 g tube: product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Marketed 1% gel in a 5 g tube.

  63. 63

    Taro-Testosterone Gel (testosterone gel 1%): product monograph, revised March 25, 2026 ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Cardiovascular warnings revised in March 2026; "Testosterone may increase blood pressure and should be used with caution in patients with hypertension."

  64. 64

    Taro-Testosterone Gel Pump 1% (12.5 mg per actuation): product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Approved 18 September 2026; not yet marketed.

  65. 65

    Natesto (testosterone nasal gel 4.5%): product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Start 11 mg twice daily (22 mg a day); increase to three times daily if needed.

  66. 66

    Taro-Testosterone (testosterone undecanoate) 40 mg capsules: product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: 120–160 mg a day in two doses for 2–3 weeks, then 40–120 mg a day, taken with meals.

  67. 67

    Jatenzo (testosterone undecanoate) 158, 198 and 237 mg capsules: product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Starts at 237 mg twice daily with food.

  68. 68

    Kyzatrex (testosterone undecanoate) 100, 150 and 200 mg capsules: product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Approved 30 June and 2 July 2026; not yet marketed.

  69. 69

    Testosterone cypionate injection USP 100 mg/mL (StériMax): product monograph ↗

    Product monograph (Canada)

    Full monograph reviewed.

    Detail: Same dosing as the Taro cypionate monograph; approved but not marketed (checked Sep 2026).

  70. 70

    DEPO-Testosterone (testosterone cypionate) injection, USP CIII ↗

    Product label (US)

    Full label reviewed.

    Detail: US cypionate is supplied at 100 and 200 mg/mL.

  71. 71

    Drug Product Database: human testosterone propionate products ↗

    Regulator database (Canada)

    Official structured records reviewed.

    Detail: No human testosterone propionate is marketed; the StériMax product has been dormant since 3 Aug 2017.

  72. 72

    Testosterone in Ontario ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: An Ontario pharmacy reported cypionate back ordered; commenters switched to enanthate or compounded testosterone.

  73. 73

    Canada Test Enan shortage? ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: Canadian pharmacies could not fill enanthate prescriptions during a back order.

  74. 74

    Amount to pay for prescription drugs (public prescription drug insurance plan) ↗

    Drug plan page (Quebec)

    Full text reviewed from an archived copy of the publisher page (23 Aug 2026); the live site blocked automated access.

    Detail: Monthly deductible $21.25, then 30% co-insurance up to a monthly maximum.

  75. 75

    Fair PharmaCare plan ↗

    Drug plan page (British Columbia)

    Official page reviewed.

    Detail: Income-based deductible and family maximum; 70% after the deductible (75% if born before 1940); 100% after the family maximum; dispensing fees up to $11 count.

  76. 76

    Fair PharmaCare assistance levels ↗

    Drug plan page (British Columbia)

    Official page reviewed.

    Detail: Families not registered have the default deductible of $10,000.

  77. 77

    Non-Group Coverage ↗

    Drug plan page (Alberta)

    Official page reviewed.

    Detail: For residents under 65: premium $63.50 single or $118 family a month ($44.45 or $82.60 subsidized); co-payment 30% up to $35 from 1 April 2026.

  78. 78

    Coverage for Seniors Program ↗

    Drug plan page (Alberta)

    Official page reviewed.

    Detail: Premium-free; co-payment 30% up to $35 from 1 April 2026.

  79. 79

    Services Not Covered by the Medical Services Plan (MSP) ↗

    Insurance page (British Columbia)

    Official page reviewed.

    Detail: MSP does not cover screening tests not supported by evidence, naming PSA tests.

  80. 80

    Canadians, what's your current TRT clinic? ↗

    Community account

    Public thread reviewed: opening post and 15 comments.

    Detail: After two years with an online clinic, the poster faced a $678 annual renewal.

  81. 81

    Canadian TRT docs SUCK!! ↗

    Community account

    Public thread reviewed: opening post and 44 comments.

    Detail: The poster paid about $8,000 a year for a private program and raised his prescribed 100 mg weekly dose himself.

  82. 82

    Should i push for trt? ↗

    Community account

    Public thread reviewed: opening post and 37 comments.

    Detail: The poster reported a private hormone panel of about $200 and a $400 first consultation.

  83. 83

    Blood done, looking for alternative ↗

    Community account

    Public thread reviewed: opening post and 15 comments.

    Detail: In Quebec, the poster reported about $150 to $200 per test paid privately.

  84. 84

    Bloodwork in Alberta ↗

    Community account

    Public thread reviewed: opening post and 10 comments.

    Detail: Alberta commenters reported private panels above $300.

  85. 85

    Looking for a clinic in Canada ↗

    Community account

    Public thread reviewed: opening post and 7 comments.

    Detail: The poster reported a $40 fee for a lab requisition from one clinic.

  86. 86

    21 CFR 1308.13(f) Schedule III: anabolic steroids ↗

    Regulation (US)

    Official text reviewed.

    Detail: Lists anabolic steroids, including testosterone and its esters, in Schedule III.

  87. 87

    Misuse of Drugs Act 1971, Schedule 2 Part III (Class C drugs) ↗

    Law (UK)

    Official text reviewed.

    Detail: Testosterone is a Class C drug.

  88. 88

    Therapeutic Goods (Poisons Standard, June 2026) Instrument 2026 ↗

    Regulation (Australia)

    Official text reviewed.

    Detail: Testosterone is in Schedule 4 (prescription only), with Appendix D possession controls.

  89. 89

    Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada ↗

    Regulator page (Canada)

    Live page reviewed (September 2026).

    Detail: Lets pharmacists extend, renew and transfer prescriptions for controlled drugs to continue treatment; expires 30 September 2026 and is revoked when the new regulations take effect on 1 October 2026.

  90. 90

    Travelling into and out of Canada with prescription medication containing controlled substances ↗

    Regulator page (Canada)

    Official page reviewed.

    Detail: Rules in force until 30 September 2026: travellers may carry the lesser of a single course of treatment or a 30-day supply of a controlled drug such as testosterone.

  91. 91

    Canadian TRT Clinc’s ↗

    Community account

    Public thread reviewed: opening post and 28 comments.

    Detail: Commenters said moving a prescription to a local pharmacy lowered medication costs.

  92. 92

    Unauthorized sexual enhancement products may pose serious health risks ↗

    Regulator advisory (Canada)

    Official page reviewed.

    Detail: Notes that anabolic steroids are regulated under the CDSA and "have a potential for abuse and dependence".

  93. 93

    Policy on Manufacturing and Compounding Drug Products in Canada (POL-0051) ↗

    Regulator policy (Canada)

    Live page reviewed (September 2026).

    Detail: Compounding only for a therapeutic need or lack of availability, not solely for economic reasons, and without duplicating an approved product.

  94. 94

    Model Standards for Pharmacy Compounding of Non-sterile Preparations ↗

    Professional standard (Canada)

    Full document reviewed.

    Detail: National model standards for non-sterile compounding, adopted by provincial pharmacy regulators.

  95. 95

    TUE Physician Guidelines: Male Hypogonadism (version 9) ↗

    Anti-doping guidance

    Full document reviewed.

    Detail: Exemptions only for organic hypogonadism, not functional low testosterone.

  96. 96

    Canadian Anti-Doping Program (2021 rules) ↗

    Anti-doping rules (Canada)

    Full rules reviewed.

    Detail: Athletes who are not international-level apply to the CCES for a TUE; it is not automatically valid at international level.

  97. 97

    Therapeutic Use Exemption (TUE) Checklist: Male Hypogonadism ↗

    Anti-doping checklist (Canada)

    Full checklist reviewed.

    Detail: "TUEs will only be granted for organic causes"; testosterone, LH, FSH and SHBG measured at least twice within four weeks, with the time of day recorded.

  98. 98

    Medications and vaccinations (eligibility) ↗

    Blood service rules (Canada)

    Official page reviewed.

    Detail: Hormone medicines alone do not stop an otherwise eligible donor.

  99. 99

    Eligibility (donation frequency) ↗

    Blood service rules (Canada)

    Official page reviewed.

    Detail: Men wait 56 days between whole-blood donations.

  100. 100

    Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE) ↗

    Human trial

    Original abstract reviewed.

    Detail: 5,204 men aged 45–80 at high heart risk; heart attack, stroke or cardiovascular death in 182 of 2,596 (7.0%) vs 190 of 2,602 (7.3%), hazard ratio 0.96 (95% CI 0.78 to 1.17), noninferior; mean treatment 21.7 months.

  101. 101

    KYZATREX (testosterone undecanoate) capsules: prescribing information ↗

    Product label (US)

    Full label reviewed.

    Detail: TRAVERSE class text: atrial fibrillation 3.5% vs 2.4%, acute kidney injury 2.3% vs 1.5%, pulmonary embolism 0.9% vs 0.5%; about 61% stopped study gel. Section 7 lists interactions with insulin, oral anticoagulants, corticosteroids and drugs that raise blood pressure.

  102. 102

    Testosterone Treatment and Fractures in Men with Hypogonadism ↗

    Human trial (substudy)

    Original abstract reviewed.

    Detail: Clinical fractures in 91 of 2,601 men on testosterone (3.50%) vs 64 of 2,603 on placebo (2.46%); hazard ratio 1.43 (95% CI 1.04 to 1.97).

  103. 103

    Summary Safety Review: Testosterone Replacement Products, Cardiovascular Risk ↗

    Regulator review (Canada)

    Full review reviewed.

    Detail: 35 Canadian reports of cardiovascular problems by August 2013; in 11, heart attack, lung clots or irregular heart rate were considered possibly related. "Health Canada is working with manufacturers to update the Canadian product label" for these possible risks.

  104. 104

    Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial ↗

    Human trial (substudy)

    Full text reviewed.

    Detail: High-grade prostate cancer in 5 of 2,596 men on testosterone (0.19%) vs 3 of 2,602 on placebo (0.12%); hazard ratio 1.62 (95% CI 0.39 to 6.77), not significant. Men with PSA above 3.0 ng/mL or severe urinary symptoms were excluded.

  105. 105

    Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline ↗

    Clinical guideline

    Full guideline reviewed.

    Detail: Stop if hematocrit is above 54% until it falls; lists untreated severe sleep apnea and thrombophilia among reasons not to start.

  106. 106

    Min-T requirements for TRT in Canada? ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: A family doctor declined treatment at 10.5 nmol/L; the poster asked whether two results below 8 nmol/L were a legal requirement.

  107. 107

    Feel like im 45, flabby, Low Libido and delayed e ↗

    Community account

    Public thread reviewed: opening post and 2 comments.

    Detail: Three falling results over a year (8, 7.5 and 6.8 nmol/L) were described by his doctor as within range.

  108. 108

    Is 9.7nmol/l low enough? 43M Canada ↗

    Community account

    Public thread reviewed: opening post and 14 comments.

    Detail: After a 9.7 nmol/L result the poster booked an online clinic; replies urged fresh morning labs and a sleep check.

  109. 109

    Online TRT clinics in Canada? ↗

    Community account

    Public thread reviewed: opening post and 27 comments.

    Detail: A family doctor offered a trial of 1% gel after two low readings.

  110. 110

    Testosterone Levels and TRT in Canada (I have questions!) ↗

    Community account

    Public thread reviewed: opening post and 4 comments.

    Detail: An online clinic declined to prescribe and advised sleep work and a repeat test in a year.

  111. 111

    Just looking for advice. ↗

    Community account

    Public thread reviewed: opening post and 22 comments.

    Detail: An online clinic approved treatment but advised a man wanting children to wait, and offered hCG.

  112. 112

    26M Bloodwork - Severely low T, feeling really confused, would love some advice ↗

    Community account

    Public thread reviewed: opening post and 4 comments.

    Detail: With a total testosterone of 4.7 nmol/L, the poster feared a six-month to one-year endocrinology wait.

  113. 113

    Looking for any and all advice ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: Facing a roughly six-month clinic wait in Manitoba, the poster obtained an unprescribed blend but had not started it.

  114. 114

    30yo Male with extremely low libido debating TRT ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: While waiting for an endocrinologist, the poster self-treated, briefly felt better, then stopped after acne.

  115. 115

    Canadian guys - how difficult is it to navigate testosterone treatment? ↗

    Community account

    Public thread reviewed: opening post and 32 comments.

    Detail: Commenters described varied provincial experiences, including a private urology visit within two weeks in Quebec.

  116. 116

    14 weeks in, and I haven't really noticed anything ↗

    Community account

    Public thread reviewed: opening post and 13 comments.

    Detail: A Nova Scotia online-clinic patient described weeks of delay and a long drive for follow-up blood work.

  117. 117

    Large variation vial to vial, what should i do? ↗

    Community account

    Public thread reviewed: opening post and 12 comments.

    Detail: The poster worried a second vial of the only marketed cypionate was weaker; replies suggested repeat testing.

  118. 118

    Return unused vials of Test, mandatory by Dr in Canada ↗

    Community account

    Public thread reviewed: opening post and 40 comments.

    Detail: An online prescriber required return of old vials before refills; other Canadians said they had not seen this.

Updates and corrections

Updated September 28, 2026. This version replaces the earlier TRT in Canada guide with a rewrite based on current federal law, Health Canada's drug database, every provincial drug-plan list we could read, medical college standards and the CUA guideline. It adds a step-by-step pathway, coverage by province, official prices, virtual-care rules by province and the rules that change on 1 October 2026. It corrects the earlier page on several points: the CUA's diagnostic threshold is 10 nmol/L (not an unspecified 8–12 nmol/L), the CUA does not require two blood draws, and it acts on hematocrit at 55% (not 54%); simple possession of testosterone is not an offence (the earlier page described up to 3 years for possession, which applies to trafficking and import); Natesto is marketed, and its dose is 5.5 mg per nostril (11 mg per dose); Depo-Testosterone and the Androderm patch are no longer sold; most provinces do list testosterone injections; virtual-care rules differ by province; and cost figures from clinic marketing pages and clinic names were removed. The date describes this revision, not a fresh check of every source.

Found an error or a relevant source we missed? Report a correction with the guide title, the specific passage and a supporting source if available. Please leave out personal health records. See our editorial policy for how we handle attribution, evidence limits and corrections.